Neumora Therapeutics, Inc. Working Capital to Net Assets Ratio
Neumora Therapeutics, Inc. working capital to net assets ratio. Neumora Therapeutics, Inc. (NMRA) has a Working Capital to Net Assets ratio of 114.4% as of September 2025. Working capital of $151.24 Million (current assets of $177.08 Million minus current liabilities of $25.84 Million) is measured against net assets of $132.16 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Neumora Therapeutics, Inc. tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Neumora Therapeutics, Inc. (2019–2024)
Working capital to net assets ratio of Neumora Therapeutics, Inc. from 2019 to 2024. This chart shows how Neumora Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 114.4%, reflecting working capital of $151.24 Million against net assets of $132.16 Million USD. See defensive interval ratio of Neumora Therapeutics, Inc. to measure how many days the company can operate on defensive assets alone.
Neumora Therapeutics, Inc. Working Capital to Net Assets Ratio by Year (2019–2024)
Neumora Therapeutics, Inc. working capital to net assets ratio by year from 2019 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Neumora Therapeutics, Inc. from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Neumora Therapeutics, Inc. assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 99.0% | $284.17 Million | $287.06 Million | $314.06 Million | $29.89 Million | ▲ +2.4 pp |
| 2023 | 96.6% | $453.17 Million | $469.08 Million | $478.28 Million | $25.11 Million | ▲ +178.1 pp |
| 2022 | -81.5% | $364.26 Million | $-446.85 Million | $387.95 Million | $23.70 Million | ▲ +39.1 pp |
| 2021 | -120.6% | $392.32 Million | $-325.22 Million | $415.60 Million | $23.28 Million | ▲ +74.8 pp |
| 2020 | -195.4% | $184.47 Million | $-94.38 Million | $193.84 Million | $9.37 Million | ▼ -295.4 pp |
| 2019 | 100.0% | $-21.00K | $-21.00K | $0.00 | $21.00K | — |